Articles

Charlie Garcia responds to readers concerned about U.S. dollar weakness, purchasing power and China’s challenge.

The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing agreements to 14.

“I just keep hoping that it will just magically go away or I’ll just die”: A growing feature of the nation’s $1.7 trillion student-debt crisis is Americans living with student loans for their entire adult lives.

A memo from TikTok’s top executive reportedly says that the social-media phenomenon inked deals to create a U.S. joint venture, with Oracle’s cloud business as its backbone.

Micron’s dramatic beat has analysts feeling upbeat about the company’s ability to be a huge beneficiary of the AI boom.

FedEx gives investors more reason to believe its overhaul is taking hold.

The government shutdown played a big part in why cheaper fares were abundant this fall. Here’s what to expect when booking your next flight.

Nike Inc. reported fiscal second-quarter results that beat Wall Street’s expectations, but its margins shrank, and management said the sneaker and athletic-gear giant was “in the middle innings” of its comeback plan.

Stocks tend to struggle during midterm election years — but 2026 could be a buying opportunity.

Bears fumble control of the tape, but the S&P 500 is still range-bound.

President Trump on Thursday signed an executive order asking the U.S. government to reschedule cannabis — a move that analysts and industry executives called the most significant federal reform on the substance in decades.

An uncertain outlook for inflation and interest rates could drive yields higher next year, weighing on bond prices.